Ilaria Casari

Kent Street
Bentley, WA 6102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

Journal: Bioscience reports

Published: January 29, 2026

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

Journal: Bioscience reports

Published: October 23, 2025

Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.

Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.

Journal: International journal of molecular sciences

Published: June 11, 2025

Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer progression.

Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer progression.

Journal: Cellular signalling

Published: January 13, 2025

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity.

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 23, 2024

Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models.

Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models.

Journal: International journal of molecular sciences

Published: January 23, 2024

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 18, 2023

Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication.

Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication.

Journal: Cytokine & growth factor reviews

Published: August 20, 2023

Can the molecules carried by extracellular vesicles help to diagnose pancreatic cancer early?

Can the molecules carried by extracellular vesicles help to diagnose pancreatic cancer early?

Journal: Biochimica et biophysica acta. General subjects

Published: January 27, 2023

Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance.

Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance.

Journal: Cancers

Published: October 28, 2022

Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine.

Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine.

Journal: Advances in biological regulation

Published: November 05, 2021

Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract.

Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract.

Journal: Pharmacological research

Published: October 12, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026